Krsnaa Diagnostics shares in focus as company announces strategic AI collaboration with AZMed
Why did Krsnaa Diagnostics Ltd shares jump today?
Shares of Krsnaa Diagnostics Ltd gained 0.53% in early trade on Thursday, with the stock trading at ₹514.95 as of 09:08 AM. The move came after the company announced a strategic AI collaboration with AZmed, a global radiology AI innovator. The company filed the press release with BSE Limited and National Stock Exchange of India Limited under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, dated October 22, 2026.
Krsnaa Diagnostics announced that it has entered into a strategic collaboration with AZmed to bring advanced artificial intelligence capabilities to its radiology operations. The partnership aims to create a platform that enhances reporting efficiency and enables scalable growth across the company's diagnostic network. AZmed is a well-known player in the global radiology AI space, and this collaboration is expected to help Krsnaa Diagnostics improve turnaround times for imaging reports while maintaining high diagnostic accuracy.
The announcement signals Krsnaa Diagnostics' commitment to adopting cutting-edge technology to stay competitive in India's rapidly growing diagnostic services market. Investors responded positively to the news, as AI-powered radiology is seen as a key differentiator that can drive operational efficiency and support the company's expansion plans. The press release has also been made available on the company's investor relations website for public access.
What does Krsnaa Diagnostics Ltd do?
Krsnaa Diagnostics Limited is a diagnostics company listed on the Bombay Stock Exchange (Scrip Code: 543328) and the National Stock Exchange of India (NSE Symbol: KRSNAA). The company operates in the diagnostics and radiology space, delivering diagnostic services with a focus on reporting efficiency and scalable growth across its operations. Krsnaa Diagnostics maintains a dedicated investor relations presence through its corporate website at krsnaadiagnostics.com.
Krsnaa Diagnostics has announced a strategic AI collaboration with AZmed, a global radiology AI innovator. This collaboration is designed to create a platform for greater reporting efficiency and scalable growth for the company, reflecting its commitment to leveraging artificial intelligence and advanced radiology technology to enhance the quality and speed of its diagnostic reporting services. The company actively engages with stock exchange listing obligations and disclosure requirements, ensuring transparent communication with stakeholders and the investing public.
Krsnaa Diagnostics Ltd Financials
In CroresKrsnaa Diagnostics Ltd reported revenue of ₹192.6 Crores in the March 2026 quarter, which increased to ₹235.53 Crores in the June 2026 quarter, representing a healthy quarter-on-quarter revenue growth of approximately 22.3%. However, the company's profitability witnessed a sharp decline during the same period, with net profit falling from ₹41.72 Crores in March 2026 to ₹16.55 Crores in June 2026 — a substantial drop of around 60.3%. This divergence between rising revenue and declining profit suggests that the company's cost structure, operational expenses, or margin pressures increased significantly during the June 2026 quarter, eroding the gains from top-line growth. While the revenue trend indicates strong demand and business expansion, the profitability trend raises concerns about margin sustainability and cost management. Investors would likely want to understand the specific drivers behind the sharp profit compression despite healthy revenue momentum.
Krsnaa Diagnostics Ltd Shareholding Pattern
Promoter holding stands at 27.11% of the total share capital. Foreign Institutional Investors (FIIs) hold 3.84% stake in the company, while Domestic Institutional Investors (DIIs) hold 14.5%. Public shareholders hold the remaining 54.55% stake in Krsnaa Diagnostics Ltd.
Krsnaa Diagnostics Ltd FAQs
Q: Why did Krsnaa shares jump 0.53% today?
Press Release on Strategic AI Collaboration with AZMed. This corporate action caught investor attention, leading to increased trading activity in the stock.
Q: What is the shareholding pattern of Krsnaa Diagnostics Ltd?
As per the latest data, promoters hold 27.11% stake in Krsnaa Diagnostics Ltd, while FII holding stands at 3.84%. Domestic institutional investors hold 14.5%, and public shareholders account for 54.55% of the equity.
Q: What is the current stock price of Krsnaa Diagnostics Ltd?
Krsnaa Diagnostics Ltd shares are currently trading at ₹514.95, recording a gain of 0.53% from the previous close.
Q: What is the market capitalization of Krsnaa Diagnostics Ltd?
The company currently has a market capitalization of ₹1753.9 crore, reflecting its valuation in the Indian equity market.